Generic Entacapone
	Generic Entacapone
	Generic Entacapone
	Generic Entacapone
	Generic Entacapone
	Generic Entacapone
	Generic Entacapone
	Comtan
	Comtan
	Comtan
	Comtan

* ENTACAPONE

Comtan Drug Information

Comtan is a medication that is used to treat Parkinson’s disease in conjunction with other drugs. This medication is specifically indicated only in those patients with Parkinsonism who show symptoms of “wearing-off” at the end of dose. This generic medication is a reversible, selective inhibitor of an enzyme called COMT. The actions of this drug are known to be brought about by its ability to suppress COMT and thereby improve the actions of Levodopa (the main anti- Parkinson’s drug that this medication is given in combination with).

Comtan Dosage Information

Entacapone is available as tablets that are to be taken with the other drugs in the regimen. The recommended dose for this medication is 200 mg that may be consumed up to eight times in 24 hours. A couple of points that patients have to remember about this drug are that Comtan is not known to have effectiveness above the recommended dose and also that it has no therapeutic effect in Parkinsonism by itself. Cheap Comtan may be purchased at North Meds for the lowest prices. Great discount Comtan is available in doses of 200 mg.

Side Effects and Precautions for Comtan

Most common side effects of Comtan are dyskinesia, nausea, hyperkinesia, abdominal pain, discoloration of urine and diarrhea. Other, less frequently seen, side effects include vomiting, dryness of mouth, fatigue, muscular pain, anxiety and difficulty in breathing. Patients must be aware of potential drug interactions between Entacapone and other drugs, particularly MAO inhibitors. Since this medication enhances the actions of Levodopa, symptoms like orthostatic hypotension may occur. Patients with known liver disease must be treated with care and monitored throughout the duration of therapy. Pregnant women and nursing mothers should only buy Comtan and use it if absolutely necessary as its safety in such patients is not conclusive known.

* All trademarks and registered trademarks are the property of their respective owners.